Академический Документы
Профессиональный Документы
Культура Документы
Pantoprazole 40mg TIV given now. For repeat Na, K, Ca, and Mg. Zykast 1 tab OD started.
Day 3 of Ceftriaxone. Day 3 of Azithromycin to complete for 5 days. Follow up Sputum GS.
Continue Aminophylline Drip. Cardiac rate monitored full minute. Modified nebulization to
alternating combivent and Salbutamol nebulization to Q2. Continue Antibiotics and
Hydrocortisone. Referred accordingly.
On the 4th hospital day, patient was seen and examined with the following vital signs:
BP 120/80 CR: 85 RR: 23 Temp:36.7C. The patient still has subjective complaints of
productive cough described as whitish and is associated with occasional chest pain
described as sharp and non-radiating and difficulty of breathing. Upon physical examination,
the patient still has bilateral crackles and wheezes. No other associated symptoms such as
nausea, vomiting, abdominal pain, and hemoptysis. Discontinuation of Oxygen
supplementation was advised and Combivent nebulization was decreased to Q4. Chest
physiotherapy was done after each nebulization. Giving of antibiotics was continued (Day 4
of Ceftriaxone and Azithromycin) and KCl tablet 1 tablet TID was started. Repeat CBC, Na, K,
and Creatinine were facilitated to be done the next day.
On the 5th hospital day, patient was seen and examined with the following vital signs:
BP: 140/80 CR: 73 RR: 20 T: 36. Still with productive cough, with whitish phlegm. No other
subjective complaints such as fever, nausea and vomiting. Still on low salt, low fat diet with
SAP, venoclyzed with D5W x 10 cc/hr. Medications were Ceftriaxone on day 4, Azithromycin
on day 3,Combivent neb q4, HAA 100mg TIV q6, Budesonide neb q12, Zykast 1 tab OD,
Furosemide 40 mg TIV q8, pantoprazole 40 mg/tab, KCL tab TID, Mupirocin ointment TID.
Chet physiotherapy was done after each nebulization.
On the 6th hospital day, patient was seen and examined with the following vital signs:
BP: 150/90 CR: 79 RR:20 T:36.8 O2: 96%. Still with productive cough, with whitish phlegm.
No other subjective complaints such as fever, nausea and vomiting. Increased oral fluid
intake. Shifted IVF to PNSS 1L x 60cc/ hr. Monitored intake and output accurately. Modify
alternating combivent and salbutamol neb to combivent nebulization Q4 only. Shift
ceftriaxone to Piperacilin-tazobactam 4.5gms IV now then 2.25 gms IV Q8. Azithromycin to